InVitae Corp (NASDAQ:NVTA) saw strong trading volume on Wednesday . 119,309 shares were traded during trading, an increase of 46% from the previous session’s volume of 81,668 shares.The stock last traded at $7.76 and had previously closed at $7.76.

A number of research analysts have weighed in on the company. Zacks Investment Research upgraded InVitae Corp from a “sell” rating to a “hold” rating in a report on Tuesday, August 23rd. Benchmark Co. assumed coverage on InVitae Corp in a report on Thursday, June 30th. They issued a “hold” rating and a $8.50 price objective on the stock. Finally, JPMorgan Chase & Co. raised their price objective on InVitae Corp from $12.00 to $14.00 and gave the company an “overweight” rating in a report on Tuesday, August 9th.

The stock’s market cap is $253.28 million. The firm’s 50-day moving average price is $8.50 and its 200 day moving average price is $8.90.

InVitae Corp (NASDAQ:NVTA) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.77) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.76) by $0.01. During the same period in the previous year, the company earned ($0.76) EPS. The business earned $5.60 million during the quarter, compared to the consensus estimate of $5.81 million. InVitae Corp’s revenue was up 211.1% compared to the same quarter last year. Equities research analysts forecast that InVitae Corp will post ($2.96) earnings per share for the current fiscal year.

Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.